DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 99 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $489,000 | -10.8% | 13,114 | -38.8% | 0.00% | 0.0% |
| Q1 2021 | $548,000 | -48.8% | 21,439 | -55.8% | 0.00% | -60.0% |
| Q4 2020 | $1,070,000 | +16.3% | 48,554 | -5.1% | 0.01% | +25.0% |
| Q3 2020 | $920,000 | -34.9% | 51,149 | -8.0% | 0.00% | -42.9% |
| Q2 2020 | $1,413,000 | +14.8% | 55,615 | -17.0% | 0.01% | -12.5% |
| Q1 2020 | $1,231,000 | +126.3% | 67,004 | +171.4% | 0.01% | +166.7% |
| Q4 2019 | $544,000 | +216.3% | 24,692 | +106.1% | 0.00% | +200.0% |
| Q3 2019 | $172,000 | -9.0% | 11,980 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $189,000 | +7.4% | 11,980 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $176,000 | – | 11,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,456,595 | $49,525,000 | 9.00% |
| COMMODORE CAPITAL LP | 1,292,251 | $26,052,000 | 6.87% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $62,098,000 | 3.85% |
| GREAT POINT PARTNERS LLC | 799,999 | $16,128,000 | 3.76% |
| DAFNA Capital Management LLC | 587,456 | $11,843,000 | 3.14% |
| Eagle Health Investments LP | 406,525 | $8,196,000 | 2.60% |
| RTW INVESTMENTS, LP | 7,582,396 | $152,861,000 | 2.30% |
| Parkman Healthcare Partners LLC | 209,686 | $4,227,000 | 1.07% |
| Palo Alto Investors LP | 855,713 | $17,251,000 | 1.04% |
| Lombard Odier Asset Management (Switzerland) SA | 701,305 | $14,138,000 | 0.88% |